The role of monocyte to high-density lipoprotein cholesterol ratio in prediction of increased systemic inflammation and the risk of cardiovascular disease in endometriosis
暂无分享,去创建一个
[1] Nan Zhang,et al. Inflammatory and Hematological Indices as Simple, Practical Severity Predictors of Microdysfunction Following Coronary Intervention: A Systematic Review and Meta-Analysis , 2020, Angiology.
[2] Zhongwei Zhu,et al. Evaluation of platelet distribution width in hypertension with hyperhomocysteinemia , 2019, Clinical and experimental hypertension.
[3] A. Usta,et al. Could hematologic parameters be useful biomarkers for the diagnosis of endometriosis? , 2019, Bratislavske lekarske listy.
[4] A. Rocha,et al. New biomarkers in endometriosis. , 2019, Advances in clinical chemistry.
[5] F. Batteux,et al. Immunology of endometriosis. , 2004, Best practice & research. Clinical obstetrics & gynaecology.
[6] A. Usta,et al. The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome , 2018, Reproductive Biology and Endocrinology.
[7] M. Akboga,et al. Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome. , 2017, Biomarkers in medicine.
[8] A. Fassbender,et al. Evaluation of Total, Active, and Specific Myeloperoxidase Levels in Women with and without Endometriosis , 2017, Gynecologic and Obstetric Investigation.
[9] F. Dede,et al. The ratio of monocyte frequency to HDL cholesterol level as a predictor of asymptomatic organ damage in patients with primary hypertension , 2017, Hypertension Research.
[10] H. Kisacik,et al. Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome. , 2016, Heart, lung & circulation.
[11] D. Aras,et al. Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[12] P. Toth. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease , 2016, Vascular health and risk management.
[13] E. Rimm,et al. Endometriosis and Risk of Coronary Heart Disease , 2016, Circulation. Cardiovascular quality and outcomes.
[14] P. Santulli,et al. Measurement of hs-CRP is irrelevant to diagnose and stage endometriosis: prospective study of 834 patients. , 2014, American journal of obstetrics and gynecology.
[15] P. Vercellini,et al. Endometriosis: pathogenesis and treatment , 2014, Nature Reviews Endocrinology.
[16] A. Prentice,et al. ESHRE guideline: management of women with endometriosis. , 2014, Human reproduction.
[17] S. Dilbaz,et al. Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma. , 2013, Journal of the Turkish German Gynecological Association.
[18] S. Cremers,et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. , 2012, Cell stem cell.
[19] R. Ferriani,et al. Unfavorable lipid profile in women with endometriosis. , 2010, Fertility and sterility.
[20] F. Geissmann,et al. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. , 2009, Annual review of immunology.
[21] R. Gold,et al. Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. , 2009, Critical reviews in immunology.
[22] I. Sekine,et al. REVIEW ARTICLE: Immunopathogenesis of Pelvic Endometriosis: Role of Hepatocyte Growth Factor, Macrophages and Ovarian Steroids , 2008, American journal of reproductive immunology.
[23] P. Wilson,et al. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. , 2008, The American journal of medicine.
[24] O. Erel,et al. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. , 2007, Human reproduction.
[25] V. Georgoulias,et al. Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls , 1994, Archives of Gynecology and Obstetrics.
[26] Sajal Gupta,et al. Role of oxidative stress in endometriosis. , 2006, Reproductive biomedicine online.
[27] A. Agarwal,et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. , 2002, Human reproduction.
[28] N. Dhalla,et al. Role of oxidative stress in cardiovascular diseases , 2000, Journal of hypertension.
[29] J. Lessing,et al. Do Soluble Cell Adhesion Molecules Play a Role in Endometriosis? , 2000, American journal of reproductive immunology.
[30] C. C. Hsu,et al. The expression of soluble intercellular adhesion molecule-1 in endometriosis. , 1998, Fertility and sterility.
[31] L. Racioppi,et al. Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions. , 1998, Human reproduction.
[32] J. Pinotti,et al. The use of biochemical markers in the diagnosis of pelvic endometriosis. , 1997, Human reproduction.
[33] A. Lemay,et al. Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. , 1996, Human reproduction.
[34] L. Fong,et al. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. , 1990, Biochimica et biophysica acta.